Cargando…
Monitoring autochthonous lung tumors induced by somatic CRISPR gene editing in mice using a secreted luciferase
BACKGROUND: In vivo gene editing of somatic cells with CRISPR nucleases has facilitated the generation of autochthonous mouse tumors, which are initiated by genetic alterations relevant to the human disease and progress along a natural timeline as in patients. However, the long and variable, orthoto...
Autores principales: | Merle, Nastasja, Elmshäuser, Sabrina, Strassheimer, Florian, Wanzel, Michael, König, Alexander M., Funk, Julianne, Neumann, Michelle, Kochhan, Katharina, Helmprobst, Frederik, Pagenstecher, Axel, Nist, Andrea, Mernberger, Marco, Schneider, André, Braun, Thomas, Borggrefe, Tilman, Savai, Rajkumar, Timofeev, Oleg, Stiewe, Thorsten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531476/ https://www.ncbi.nlm.nih.gov/pubmed/36192757 http://dx.doi.org/10.1186/s12943-022-01661-2 |
Ejemplares similares
-
p53 partial loss-of-function mutations sensitize to chemotherapy
por: Klimovich, Boris, et al.
Publicado: (2021) -
Mutant p53-ENTPD5 control of the calnexin/calreticulin cycle: a druggable target for inhibiting integrin-α5-driven metastasis
por: Pavlakis, Evangelos, et al.
Publicado: (2023) -
Loss of p53 function at late stages of tumorigenesis confers ARF-dependent vulnerability to p53 reactivation therapy
por: Klimovich, Boris, et al.
Publicado: (2019) -
Monitoring the dynamics of clonal tumour evolution in vivo using secreted
luciferases
por: Charles, Joël P., et al.
Publicado: (2014) -
Residual apoptotic activity of a tumorigenic p53 mutant improves cancer therapy responses
por: Timofeev, Oleg, et al.
Publicado: (2019)